Relevant conflict of interest: Nothing to report.
Meta-analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson's disease†
Version of Record online: 2 MAR 2011
Copyright © 2011 Movement Disorder Society
Volume 26, Issue 4, pages 587–598, March 2011
How to Cite
Stowe, R., Ives, N., Clarke, C. E., Handley, K., Furmston, A., Deane, K., van Hilten, J.J., Wheatley, K. and Gray, R. (2011), Meta-analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson's disease. Mov. Disord., 26: 587–598. doi: 10.1002/mds.23517
- Issue online: 19 APR 2011
- Version of Record online: 2 MAR 2011
- Manuscript Accepted: 13 OCT 2010
- Manuscript Revised: 3 SEP 2010
- Manuscript Received: 12 JAN 2010
Additional Supporting Information may be found in the online version of this article.
|MDS_23517_sm_suppinfotab1.doc||51K||Web Table 1: Intraclass Comparisons for Off-Time Reduction, Levodopa Dose Reduction, Clinician-Rated Disability, Dyskinesia and Overall Side-Effects|
|MDS_23517_sm_suppinfotab2.doc||36K||Web Table 2: Interclass Comparisons for Other Side-Effects|
|MDS_23517_sm_PRISMA2009Checklis.doc||61K||PRISMA 2009 Checklist|
|MDS_23517_sm_PRISMA2009Diagram.doc||32K||PRISMA 2009 Flow Diagram|
|MDS_23517_sm_RCTsinMedline.doc||33K||Search Strategy used to identify RCTs in Medline|
|MDS_23517_sm_suppinfofig1.tif||2294K||Supporting Figure 1|
|MDS_23517_sm_suppinfofig2.tif||2754K||Supporting Figure 2|
|MDS_23517_sm_suppinfofig3.tif||2496K||Supporting Figure 3|
|MDS_23517_sm_suppinfofig4.tif||2762K||Supporting Figure 4|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.